Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glypican-1 (GPC1) mRNA is the messenger RNA transcript that encodes the GPC1 protein, a cell surface heparan sulfate proteoglycan (HSPG) attached to the membrane via a glycosylphosphatidylinositol (GPI) anchor. This molecule serves as a critical template for the production of GPC1, which acts as a co-receptor for various heparin-binding growth factors, including fibroblast growth factors (FGFs) and vascular endothelial growth factor (VEGF), thereby regulating cell signaling, proliferation, and angiogenesis (PubMed: 9537005). GPC1 mRNA is frequently overexpressed in several aggressive cancers, most notably pancreatic ductal adenocarcinoma and glioblastoma, where it promotes tumor growth and metastasis (PubMed: 16452190). As a therapeutic target, GPC1 mRNA is approached using RNA interference (RNAi) or antisense oligonucleotides (ASOs) to silence the expression of the GPC1 protein, effectively disrupting the oncogenic signaling pathways it supports (PubMed: 28213458). Furthermore, the detection of GPC1 mRNA and its protein product in circulating exosomes has emerged as a promising non-invasive biomarker for early cancer detection and monitoring (Nature: 26108854). Therapeutic challenges include the efficient delivery of nucleic acid-based drugs to the tumor site and avoiding off-target effects within the transcriptome.
Inhibition of protein translation through RNA interference (RNAi) or antisense-mediated degradation of the mRNA transcript, leading to reduced expression of the Glypican-1 protein.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glypican-1 messenger RNA (GPC1 mRNA) (GPC1 mRNA).